Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

The first perpetual futures for Russian shares will appear on the Moscow Stock Exchange

9/25/24 MOEX

Polyus received the first gold from Sukhoi Log ore

9/25/24 PLZL

Shareholders of Novorossiysk Bakery Products Plant approved dividends

9/25/24 NKHP

Shareholders of Novorossiysk Bakery Products Plant approved dividends for 6 months 2024

9/25/24 NKHP

MTS invests in data center construction ₽20 billion

9/25/24 MTSS

Resale Market opened its second regional office

9/25/24 MGKL

Headhunter to allocate up to ₽35 billion to dividends

9/24/24 HEAD

LME changed its mind about stopping supplies from Nornickel's plant in Finland

9/24/24 GMKN

Cian Holding Company completed redomiciliation to Russia

9/24/24 CIAN

Novatek launched the third hydrocracking unit at Ust-Luga

9/24/24 NVTK